Patricia B.
CEO, Board Member, Inventor, Investor, Kauffman Fellow and Mentor.
- Role
- Independent Board Member at Fe Pharmaceuticals
- Location
- Seattle, WA, US
- LinkedIn followers
- 500 followers
About Patricia B.
Entrepreneurial bioscience professional - scientist, business advisor, board member, investor and reformed venture capitalist. Co-inventor of marketed drug Enbrel (worldwide sales over $6B annually) and over 40 issued U.S. Patents. Experience in multiple platforms, therapeutic and diagnostic disciplines. Qualified operational manager effective in leading early-stage companies. Broad network of relationships. Professional reputation for integrity, creativity, communication, building teams and adding value.
Experience
Independent Board Member
Jan 2020 — Present · San Francisco, NS, CA
Fe Pharmaceuticals is developing a non-toxic, iron-binding copolymer as a human therapeutic. Potent activities include broad-spectrum, anti-infective agent active against bacterial and fungal infections, including drug resistant organisms. Phase 1 clinical studies planned for CAP and secondary studies in cancer. Phase 2 studies in canine otitis externa have been successfully completed.
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.